Researchers at the University of Cologne and the Center for Genomic Regulation (CRG) in Barcelona have discovered that cancer ...

HOUSTON -- Progression-free survival (PFS) in IDH -mutant low-grade glioma remained twice as high in adults who received ...

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

The authors found that a higher mtDNA copy number led to an increase in tumor volume. The general rise in mtDNA copy numbers did not alter the immune cell infiltration in the lung and selective ...

Presented Encouraging Phase 2 Data on NUC-7738 in Combination with Pembrolizumab at the European Society for Medical Oncology (ESMO) Congress ...

Recent evidence underscores the pivotal role of communication between cancer and non-malignant cells within the tumor microenvironment (TME) in driving malignant progression. The TME, characterized by ...

Researchers discovered that tumors grow uniformly throughout their mass, challenging the idea of faster growth at edges.

Treatment with pimicotinib achieved a 54% objective response rate at 25 weeks vs 3.2% with placebo in patients with TGCT, ...